TY - JOUR
T1 - Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection
AU - Cinesi Gómez, César
AU - Peñuelas Rodríguez, Óscar
AU - Luján Torné, Manel
AU - Egea Santaolalla, Carlos
AU - Masa Jiménez, Juan Fernando
AU - García Fernández, Javier
AU - Carratalá Perales, José Manuel
AU - Heili-Frades, Sarah Béatrice
AU - Ferrer Monreal, Miquel
AU - de Andrés Nilsson, José M.
AU - Lista Arias, Eva
AU - Sánchez Rocamora, Juan Luis
AU - Garrote, José Ignacio
AU - Zamorano Serrano, Miguel J.
AU - González Martínez, Mónica
AU - Farrero Muñoz, Eva
AU - Mediano San Andrés, Olga
AU - Rialp Cervera, Gemma
AU - Mas Serra, Arantxa
AU - Hernández Martínez, Gonzalo
AU - de Haro López, Candelaria
AU - Roca Gas, Oriol
AU - Ferrer Roca, Ricard
AU - Romero Berrocal, Antonio
AU - Ferrando Ortola, Carlos
N1 - Publisher Copyright:
© 2020
PY - 2020/7
Y1 - 2020/7
N2 - Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.
AB - Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.
KW - Aerosol-generating procedures
KW - High-flow nasal therapy
KW - Infection control
KW - Non-invasive mechanical ventilation
UR - https://www.scopus.com/pages/publications/85083643322
U2 - 10.1016/j.arbres.2020.03.005
DO - 10.1016/j.arbres.2020.03.005
M3 - Article
C2 - 34629620
AN - SCOPUS:85083643322
SN - 0300-2896
VL - 56
SP - 11
EP - 18
JO - Archivos de Bronconeumologia
JF - Archivos de Bronconeumologia
ER -
